James Frates serves as Chief Financial Officer at Amylyx Pharmaceuticals. Prior to joining Amylyx, he was Alkermes Chief Financial Officer for almost 23 years through its growth from a clinical stage company to an international commercial and development enterprise with multiple products in CNS, over $1 billion in revenue and over 2,000 employees. Earlier in his career, Jim was a Vice President in charge of the East Coast Life Sciences Practice at Robertson Stephens & Company. He also worked in healthcare investment banking at Morgan Stanley & Company and spent a year teaching secondary school at the Royal Shrewsbury School in the U.K., as the Harvard College Fellow. Jim served on the Board of Directors of GPC Biotech AG from June 2004 to June 2009 and was a national director of the Association of Bioscience Financial Officers. He also serves as a Trustee for St. Francis House, Boston’s largest day shelter for the homeless. He has previously served as a trustee and Treasurer for the Roxbury Latin School and St Paul’s School. Jim received a Bachelor of Arts degree in government from Harvard College and a Master of Business Administration from Harvard Graduate School of Business Administration.